Cermin Dunia Kedokteran: Announcements

Cermin Dunia Kedokteran: Announcements https://cdkjournal.com/index.php/cdk <ol> <li>Journal Title: <a title="Cermin Dunia Kedokteran" href="https://cdkjournal.com/">Cermin Dunia Kedokteran</a></li> <li>Initials: CDK</li> <li>Frequency: monthly/year</li> <li>Online ISSN: <a href="https://portal.issn.org/resource/ISSN/2503-2720" target="_blank" rel="noopener">2503-2720</a></li> <li>TD-PSE (Kominfo): 003119.02/DJAI.PSE/07/2022</li> <li>DOI in Crossref: 10.55175</li> <li>Editor in Chief: Dr. dr. Budi Riyanto Wreksoatmodjo, SpN</li> <li>Publisher and Managed by: <a href="https://www.kalbe.co.id/en" target="_blank" rel="noopener">PT Kalbe Farma Tbk</a>.</li> <li>Accreditation Number: <a href="https://cdkjournal.com/index.php/cdk/accreditation" target="_blank" rel="noopener">No. 152/E/KPT/2023</a> (<a href="https://sinta.kemdikbud.go.id/journals?q=25032720" target="_blank" rel="noopener">SINTA 4</a>) Periode Akreditasi: Volume 48 Nomor 6 Tahun 2021 sampai Volume 53 Nomor 5 Tahun 2026 </li> </ol> <div>Cermin Dunia Kedokteran (CDK) is a scientific medical journal focused on the development of medical science, pharmacy, and public health, oriented toward evidence-based practice, service innovation, and the integration of health policies in local, national, and global contexts. Manuscripts are published under an <a href="https://cdkjournal.com/index.php/cdk/open-access-policy-and-license" target="_blank" rel="noopener">open-access policy.</a> Manuscripts undergo a double-blind <a href="https://cdkjournal.com/index.php/cdk/peer-review-process" target="_blank" rel="noopener">peer review process</a>; at least two reviewers will review manuscripts relevant to the topic of the manuscript. The journal is published monthly (January to December). The CDK Journal accepts research manuscripts, systematic review, meta-analyses, evidence-based case report, case report, and literature review.</div> Submitted manuscripts must be original (written by the authors themselves and not the result of plagiarism) and must not be simultaneously submitted to, under review by, or in the process of publication in another journal or conference. Articles that fall outside the scope of the CDK Journal will not be processed for publication. Please read and follow the<a href="https://cdkjournal.com/index.php/cdk/author-guidelines"> author guidelines</a>. <div>Currently, submissions to CDK are subject to a publication fee (IDR Rp500,000,-), payable in advance, for systematic reviews, meta-analyses, evidence-based case reports, literature reviews, and case reports; however, primary research manuscripts that are eligible for publication are exempt from the publication fee.</div> <div> Articles involving foreign authors (authors from abroad or Indonesian authors affiliated with institutions abroad) will be exempt from fees, regardless of whether they are the first, second, or subsequent authors.</div> <div> </div> <div> IMPORTANT NOTICE* Effective October 5th, 2026, CDK Journal is temporarily not accepting new Literature Review submissions. We will still accept research articles, systematic reviews, meta-analyses, and case reports. Literature Review manuscripts that have already been submitted will continue to be processed through the editorial and peer-review process. *This information is valid until further notice </div> en-US Thu, 20 Apr 2023 16:49:17 +0700 OJS 3.3.0.13 http://blogs.law.harvard.edu/tech/rss 60